Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.

Clinical trial NCT06130384 · COMPLETED

Trial details

NCT number: NCT06130384
Sponsor: Wills Eye
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pain Intravitreal Injection Pain, Acute

Start date: 2021-03-01
Primary completion: 2023-08-15
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.